Psoriasis: topical corticosteroid therapy. 1976

Y Lynfield, and M Watsky

Fifty-nine patients with bilateral psoriatic lesions were subjects in a double-blind paired comparison of halcinonide cream and fluocinonide cream. They applied the corticosteroid creams twice a day for 14 days without occlusive dressings. Objective and subjective assessment of response to therapy was made four or five days, one week, and two weeks after starting treatment. The results were analyzed by statistical methods. At the second visit (day 4 or 5), there was little difference between the two compounds, but at visits three and four, reduction of inflammation was significantly better with halcinonide than with fluocinonide.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D005446 Fluocinolone Acetonide A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) Fluortriamcinolone Acetonide,Alvadermo,Capex,Co-Fluocin,Cortiespec,Derma-Smooth FS,Flucinar,Fluocid,Fluodermo,Fluonid,Fluotrex,Flurosyn,Flusolgen,Gelidina,Jellin,Jellisoft,Synalar,Synalar-HP,Synamol,Synemol,Acetonide, Fluocinolone,Acetonide, Fluortriamcinolone,Co Fluocin,Derma Smooth FS,Synalar HP
D005447 Fluocinonide A topical glucocorticoid used in the treatment of ECZEMA. Fluocinolide,Fluocinolone Acetonide 21-Acetate,Fluocinonide FAPG,Klariderm,Lidemol,Lidex,Lyderm,Metosyn,Novoter,Tiamol,Topsym,Topsyn,Topsyne,Acetonide 21-Acetate, Fluocinolone,FAPG, Fluocinonide,Fluocinolone Acetonide 21 Acetate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Y Lynfield, and M Watsky
October 1990, Cutis,
Y Lynfield, and M Watsky
August 1991, Cutis,
Y Lynfield, and M Watsky
January 2006, Acta dermatovenerologica Croatica : ADC,
Y Lynfield, and M Watsky
September 2007, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti,
Y Lynfield, and M Watsky
January 1978, Modern medicine of Asia,
Y Lynfield, and M Watsky
May 1981, Missouri medicine,
Y Lynfield, and M Watsky
April 1976, Cutis,
Y Lynfield, and M Watsky
February 1999, American family physician,
Y Lynfield, and M Watsky
January 1972, Acta dermato-venereologica,
Copied contents to your clipboard!